Moderna Will Start To Outrun Coronavirus Competition In 2021, Analyst Says By: TalkMarkets September 25, 2020 at 16:30 PM EDT Oppenheimer analyst Hartaj Singh maintained an Outperform rating and a $108 price target. Read More >> Related Stocks: Moderna Inc Pfizer